Page last updated: 2024-09-03

293b cpd and Insulin Resistance

293b cpd has been researched along with Insulin Resistance in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, L; Lu, H; Ren, X; Wang, F; Zou, J	1

Other Studies

1 other study(ies) available for 293b cpd and Insulin Resistance

Article	Year
Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice. Islets, 2014, Volume: 6, Issue:4 Topics: Animals; Chromans; Fluorescent Antibody Technique; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; In Vitro Techniques; Insulin; Insulin Resistance; Insulin Secretion; Intestines; Islets of Langerhans; KCNQ1 Potassium Channel; Mice; Pancreas; Sulfonamides	2014

Article

Year

Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.

Islets, 2014, Volume: 6, Issue:4

Topics: Animals; Chromans; Fluorescent Antibody Technique; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; In Vitro Techniques; Insulin; Insulin Resistance; Insulin Secretion; Intestines; Islets of Langerhans; KCNQ1 Potassium Channel; Mice; Pancreas; Sulfonamides

2014